Long-term marijuana use may cause cancer
the ONA take:
According to a new study published in the journal Addiction, researchers at the University of Queensland in Queensland, Australia, have found that long-term marijuana smoking can lead to the development of cancer and doubles the risk of developing the psychiatric disorder schizophrenia.
For the 20-year study, the researchers analyzed various studies involving marijuana use over the two decades. They found that teenagers who use cannabis regularly are approximately twice as likely as nonusers to drop out of school, experience cognitive impairment, develop psychoses.
They found no report of marijuana overdoses leading to death and conclude that the risk of suffering a fatal overdose from marijuana is extremely small. In addition, the researchers found that middle-age adults who smoke cannabis regularly are at increased risk for experiencing a myocardial infarction.
Despite finding an increased risk for cancer and bronchitis, the association between marijuana use and those diseases remain unclear because most cannabis smokers included in the study had smoked or continue to smoke tobacco, a known cause of both diseases.
Marijuana smoking can lead to the development of cancer.
Smoking marijuana over the long-term can develop cancer and doubles the risk of developing schizophrenia, a new study has revealed. The 20-year research study conducted by Professor Wayne Hall, an adviser to the World Health Organisation (WHO), belies assumptions that cannabis has no negative side effects.
Long-term use of marijuana can cause cancer, bronchitis, and heart attacks reports Hall's paper, published in the journal Addiction. Researchers also found that one in six teenagers and one in ten adults who regularly smoke cannabis become dependent on it. Teenagers who use the drug are also more likely to drop out of school and develop psychotic disorders and cognitive impairment.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|